Area of research
Public Health, Environmental and Occupational Health · Oncology
Research interest
Research interests include Opioid Use Disorder Treatment, COVID-19 and healthcare impacts, Pharmaceutical Practices and Patient Outcomes, and Medication Adherence and Compliance.
Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELY
Outpatient hospital attendances in people with rheumatoid arthritis during the COVID-19 pandemic and beyond: a cohort study in three nations of the UK
Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)
Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis
OpenSAFELY: The impact of COVID‐19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate
Changes in sick notes associated with COVID-19 from 2020 to 2022: a cohort study in 24 million primary care patients in OpenSAFELY-TPP
Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform
Five-Year Trajectories of Prescription Opioid Use
Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions
Changes in antibiotic prescribing following COVID‐19 restrictions: Lessons for post‐pandemic antibiotic stewardship
Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006‐2016: A study in the five Nordic countries, United States, and Australia
Antipsychotic drug use in pregnancy: A multinational study from ten countries
Adherence to Antiretroviral Regimens in Australia: A Nationwide Cohort Study
Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP)
Codeine use and harms in Australia: evaluating the effects of re‐scheduling
Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP)
Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP)
Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings
The crux of the matter: Did the ABC's Catalyst program change statin use in Australia?
Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management